Motif ID: Hoxb8_Pdx1
Z-value: 0.675
Transcription factors associated with Hoxb8_Pdx1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Hoxb8 | ENSMUSG00000056648.4 | Hoxb8 |
Pdx1 | ENSMUSG00000029644.6 | Pdx1 |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.8 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
1.0 | 5.1 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.9 | 12.2 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.9 | 3.7 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.9 | 7.8 | GO:0060373 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.8 | 3.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.8 | 2.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.7 | 6.6 | GO:0061470 | interleukin-21 production(GO:0032625) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) |
0.5 | 7.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 5.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.4 | 2.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.4 | 1.7 | GO:0031622 | positive regulation of fever generation(GO:0031622) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.4 | 1.6 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.4 | 1.2 | GO:0051030 | snRNA transport(GO:0051030) |
0.4 | 4.6 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.4 | 5.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.3 | 0.9 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.3 | 4.5 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.2 | 1.2 | GO:0019659 | fermentation(GO:0006113) lactate biosynthetic process from pyruvate(GO:0019244) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.2 | 9.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 3.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 1.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.6 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.2 | 1.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 5.3 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.8 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 0.6 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 1.3 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 1.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 11.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 2.8 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.4 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 1.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.4 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
0.1 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 3.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 7.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 1.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 2.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 1.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.6 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 4.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.6 | GO:0019227 | neuronal action potential propagation(GO:0019227) detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) action potential propagation(GO:0098870) |
0.1 | 0.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.2 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.6 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.3 | GO:1902302 | phosphorelay signal transduction system(GO:0000160) regulation of potassium ion export(GO:1902302) |
0.0 | 0.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 1.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 3.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.3 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.0 | 0.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.7 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.2 | GO:0018377 | N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
0.0 | 0.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.1 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.0 | 0.0 | GO:0061056 | sclerotome development(GO:0061056) |
0.0 | 3.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.2 | GO:0006816 | calcium ion transport(GO:0006816) |
0.0 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.9 | GO:0042168 | heme metabolic process(GO:0042168) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.0 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.8 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.9 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.5 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.0 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.0 | 0.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 1.1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.6 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.8 | 2.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 7.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 4.9 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 12.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.4 | 2.4 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 4.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 4.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 8.0 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 10.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.5 | GO:0000235 | astral microtubule(GO:0000235) |
0.1 | 1.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 11.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
0.1 | 3.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 3.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 6.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.8 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 7.2 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.5 | GO:0033655 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.0 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 1.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 1.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.8 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.9 | GO:0005770 | late endosome(GO:0005770) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.1 | 7.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.0 | 4.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.9 | 4.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.7 | 7.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 2.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.6 | 4.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.5 | 1.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 3.3 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.4 | 12.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.4 | 4.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 2.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 1.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 4.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 3.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 3.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.6 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.2 | 0.4 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.2 | 0.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.2 | 4.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 4.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 1.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 1.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 1.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.4 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
0.1 | 2.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 2.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 2.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 6.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0004335 | galactokinase activity(GO:0004335) |
0.0 | 0.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.7 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 1.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 1.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.3 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 10.5 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 1.7 | GO:0008144 | drug binding(GO:0008144) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 6.2 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 2.2 | GO:0008017 | microtubule binding(GO:0008017) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.1 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 6.2 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 4.6 | PID_BMP_PATHWAY | BMP receptor signaling |
0.1 | 3.3 | PID_REELIN_PATHWAY | Reelin signaling pathway |
0.1 | 0.8 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
0.1 | 7.8 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
0.0 | 1.7 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
0.0 | 0.9 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
0.0 | 2.2 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.7 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
0.0 | 0.7 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 1.6 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 2.8 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.1 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.4 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.0 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
0.0 | 0.9 | PID_P53_REGULATION_PATHWAY | p53 pathway |
0.0 | 0.2 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
0.4 | 11.3 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 12.7 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 10.5 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 12.2 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
0.2 | 4.6 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 2.6 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 4.1 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 3.3 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 4.6 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.7 | REACTOME_REGULATION_OF_COMPLEMENT_CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 2.5 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.1 | 4.4 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.8 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.6 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.4 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 5.3 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.4 | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 5.7 | REACTOME_L1CAM_INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.3 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.9 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.2 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.6 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.8 | REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 2.3 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 2.3 | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.7 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.6 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.6 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.6 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.4 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.3 | REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 1.2 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.5 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.5 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.4 | REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.1 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.2 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |